Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Action of Dipeptidyl Peptidase-4 Inhibitors on SARS-CoV-2 Main Protease
Herbert Nar et al.
CHEMMEDCHEM (2021)
Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis
Bhavya Vishwa et al.
PHARMACEUTICS (2021)
Thymol Nanoemulsion: A New Therapeutic Option for Extensively Drug Resistant Foodborne Pathogens
Mahmoud M. Bendary et al.
ANTIBIOTICS-BASEL (2021)
Repurposing of antidiabetics as Serratia marcescens virulence inhibitors
Wael A. H. Hegazy et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2021)
Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications
Andrey Santos et al.
DIABETOLOGY & METABOLIC SYNDROME (2021)
Synthesis of Gold Nanoparticles by Using Green Machinery: Characterization and In Vitro Toxicity
Ahmed Al Saqr et al.
NANOMATERIALS (2021)
Xylitol Inhibits Growth and Blocks Virulence in Serratia marcescens
Ahdab N. Khayyat et al.
MICROORGANISMS (2021)
Efficacy of SPG-ODN 1826 Nanovehicles in Inducing M1 Phenotype through TLR-9 Activation in Murine Alveolar J774A.1 Cells: Plausible Nano-Immunotherapy for Lung Carcinoma
Mohammed F. Aldawsari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Celastrol Modulates Multiple Signaling Pathways to Inhibit Proliferation of Pancreatic Cancer via DDIT3 and ATF3 Up-Regulation and RRM2 and MCM4 Down-Regulation
Mahmoud Youns et al.
ONCOTARGETS AND THERAPY (2021)
Not Only Antimicrobial: Metronidazole Mitigates the Virulence of Proteus mirabilis Isolated from Macerated Diabetic Foot Ulcer
Ahdab N. Khayyat et al.
APPLIED SCIENCES-BASEL (2021)
Tackling Virulence of Pseudomonas aeruginosa by the Natural Furanone Sotolon
Mohammed F. Aldawsari et al.
ANTIBIOTICS-BASEL (2021)
Sitagliptin: a potential drug for the treatment of COVID-19?
Sanaa K. Bardaweel et al.
ACTA PHARMACEUTICA (2021)
Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2
Abhinit Kumar et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Second-Generation Antidiabetic Sulfonylureas Inhibit Candida albicans and Candidalysin-Mediated Activation of the NLRP3 Inflammasome
David J. Lowes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis
Meng Zhang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Metformin promotes Mycobacterium tuberculosis killing and increases the production of human b-defensins in lung epithelial cells and macrophages
Adrian Rodriguez-Carlos et al.
MICROBES AND INFECTION (2020)
Assessment of alpha glucosidase inhibitors produced from endophytic fungus Alternaria destruens as antimicrobial and antibiofilm agents
Jasleen Kaur et al.
MOLECULAR BIOLOGY REPORTS (2020)
Mechanisms and Characteristics of Sulfonylureas and Glinides
Wei Lv et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Investigating the influence of iron on Campylobacter jejuni transcriptome in response to acid stress
Momen Askoura et al.
MICROBIAL PATHOGENESIS (2020)
Role of gut microbiota in type 2 diabetes pathophysiology
Manoj Gurung et al.
EBIOMEDICINE (2020)
Helicobacter pylori infection as a risk factor for diabetes: a meta-analysis of case-control studies
Kamyar Mansori et al.
BMC GASTROENTEROLOGY (2020)
Benefits of Metformin in Attenuating the Hallmarks of Aging
Ameya S. Kulkarni et al.
CELL METABOLISM (2020)
The role of immune cells in obesogenic memory
Minli Sun et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Alterations in Gut Microbiota of Gestational Diabetes Patients During the First Trimester of Pregnancy
Shujuan Ma et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Ciprofloxacin interferes with Salmonella Typhimurium intracellular survival and host virulence through repression of Salmonella pathogenicity island-2 (SPI-2) genes expression
Momen Askoura et al.
PATHOGENS AND DISEASE (2020)
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Federica Zatterale et al.
FRONTIERS IN PHYSIOLOGY (2020)
Gut Microbiota beyond Bacteria-Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD
Mario Matijasic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung
Farzaneh Dastan et al.
IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY (2020)
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Ygor Parladore Silva et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Repurposing anti-diabetic drug Sitagliptin as a novel virulence attenuating agent in Serratia marcescens
Hisham A. Abbas et al.
PLOS ONE (2020)
Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?
Rima M. Chakaroun et al.
NUTRIENTS (2020)
Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time ofCOVID-19 pandemic
Marco Infante et al.
JOURNAL OF DIABETES (2020)
Metformin Restores Tetracyclines Susceptibility against Multidrug Resistant Bacteria
Yuan Liu et al.
ADVANCED SCIENCE (2020)
Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes
Alina Kurylowicz et al.
MOLECULES (2020)
Diabetes, obesity andCOVID-19: A complex interplay
Prashanth Vas et al.
DIABETES OBESITY & METABOLISM (2020)
α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19
Spencer J. Williams et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
Hydroxychloroquine-Associated Hypoglycemia in Hemodialysis Patients With COVID-19
Ahmet Burak Dirim et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
Sebastiano Bruno Solerte et al.
DIABETES CARE (2020)
Anti-inflammatory properties of antidiabetic drugs: A promised land in the COVID-19 era?
Niki Katsiki et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2020)
Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin
Negin Mozafari et al.
MEDICAL HYPOTHESES (2020)
Impact of sodium-glucose cotransporter-2 inhibitors-induced glucosuria in the incidence of urogenital infection on postmenopausal women with diabetes
Luiz Paulo Jose Marques et al.
POSTGRADUATE MEDICINE (2020)
Metformin enhances protection in guinea pigs chronically infected with Mycobacterium tuberculosis
Jessica D. Haugen Frenkel et al.
SCIENTIFIC REPORTS (2020)
Repurposing Anti-diabetic Drugs to Cripple Quorum Sensing inPseudomonas aeruginosa
Wael A. H. Hegazy et al.
MICROORGANISMS (2020)
Promising Antibiofilm Agents: Recent Breakthrough against Biofilm Producing Methicillin-Resistant Staphylococcus aureus
Marwa I. Abd El-Hamid et al.
ANTIBIOTICS-BASEL (2020)
Type 2 Diabetes and its Impact on the Immune System
Afiat Berbudi et al.
CURRENT DIABETES REVIEWS (2020)
Rifampicin Alters Metformin Plasma Exposure but Not Blood Glucose Levels in Diabetic Tuberculosis Patients
Lindsey H. M. te Brake et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Higher abundance of enterovirus A species in the gut of children with islet autoimmunity
Ki Wook Kim et al.
SCIENTIFIC REPORTS (2019)
Impact of Gut Microbiota on Host Glycemic Control
Celine Gerard et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis
Xiaoyu Liao et al.
EBIOMEDICINE (2019)
Metformin in tuberculosis: beyond control of hyperglycemia
William Oglesby et al.
INFECTION (2019)
Pioglitazone improves phagocytic activity of liver recruited macrophages in elderly mice possibly by promoting glucose catabolism
Masahiro Nakashima et al.
INNATE IMMUNITY (2019)
Antidiabetic Drugs and Their Nanoconjugates Repurposed as Novel Antimicrobial Agents against Acanthamoeba castellanii
Ayaz Anwar et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2019)
Quorum Sensing: A Prospective Therapeutic Target for Bacterial Diseases
Qian Jiang et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Potential protective effects of Dapagliflozin in gentamicin induced nephrotoxicity rat model via modulation of apoptosis associated miRNAs
Doaa I. Mohamed et al.
GENE (2019)
Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis
Noelly Queiroz Ribeiro et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Type 2 Diabetes: How Much of an Autoimmune Disease?
Paola de Candia et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Human Amylin: From Pathology to Physiology and Pharmacology
Wei Ling et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2019)
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Marc Foretz et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Factors affecting the composition of the gut microbiota, and its modulation
Nihal Hasan et al.
PEERJ (2019)
Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review
Xinyu Yu et al.
BMC INFECTIOUS DISEASES (2019)
Microbial Metabolism Modulates Antibiotic Susceptibility within the Murine Gut Microbiome
Damien J. Cabral et al.
CELL METABOLISM (2019)
Pathogenesis and clinical management of Helicobacter pylori gastric infection
Breno Bittencourt de Brito et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors
Nobuo Fuke et al.
NUTRIENTS (2019)
Effect of α-glycosidase inhibitors from endophytic fungus Alternaria destruens on survival and development of insect pest Spodoptera litura Fab. and fungal phytopathogens
Jasleen Kaur et al.
SCIENTIFIC REPORTS (2019)
Helicobacter pylori and cardiovascular disease: update 2019
Irena Mladenova
MINERVA CARDIOANGIOLOGICA (2019)
Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development
Katarzyna Siewko et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Enterovirus infection and type 1 diabetes: unraveling the crime scene
T. Rodriguez-Calvo
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
The diabetes pandemic and associated infections: suggestions for clinical microbiology
Antonio Toniolo et al.
REVIEWS IN MEDICAL MICROBIOLOGY (2019)
The Photomodulation Activity of Metformin Against Oral Microbiome
Shima Afrasiabi et al.
JOURNAL OF LASERS IN MEDICAL SCIENCES (2019)
The Interaction of Helicobacter pylori Infection and Type 2 Diabetes Mellitus
Seyed Hosseininasab Nodoushan et al.
ADVANCED BIOMEDICAL RESEARCH (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Metformin Mediates Protection against Legionella Pneumonia through Activation of AMPK and Mitochondrial Reactive Oxygen Species
Chiaki Kajiwara et al.
JOURNAL OF IMMUNOLOGY (2018)
High glucose-mediated overexpression of ICAM-1 in human vaginal epithelial cells increases adhesion of Candida albicans
Hiroshige Mikamo et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2018)
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Daniel J. Drucker
CELL METABOLISM (2018)
Cutaneous Granulomatosis: a Comprehensive Review
Benedetta Terziroli Beretta-Piccoli et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)
Gut microbiome in type 1 diabetes: A comprehensive review
Peilin Zheng et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)
Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes
Amir-Babak Sioofy-Khojine et al.
DIABETOLOGIA (2018)
Persistent and severe hypoglycemia associated with trimethoprim-sulfamethoxazole in a frail diabetic man on polypharmacy: A case report and literature review
Raffaella Rossio et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2018)
Insulin resistance causes inflammation in adipose tissue
Mitsugu Shimobayashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
The Burden of Rifampicin- and Methicillin-Resistant Staphylococcus aureus in Italy
Dafne Bongiorno et al.
MICROBIAL DRUG RESISTANCE (2018)
Antidiabetic gliptins affect biofilm formation by Streptococcus mutans
Arpan De et al.
MICROBIOLOGICAL RESEARCH (2018)
Interaction of antidiabetic α-glucosidase inhibitors and gut bacteria α-glucosidase
Kemin Tan et al.
PROTEIN SCIENCE (2018)
Cardiovascular Safety, Long-Term Noncardiovascular Safety, and Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis With Trial Sequential Analysis
Xin-Lin Zhang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey
Ann Versporten et al.
LANCET GLOBAL HEALTH (2018)
Metformin and Autoimmunity: A New Deal of an Old Drug
Francesco Ursini et al.
FRONTIERS IN IMMUNOLOGY (2018)
Herpes Zoster and Diabetes Mellitus: A Review
Marianthi Papagianni et al.
DIABETES THERAPY (2018)
Herpes Zoster and Diabetes Mellitus: A Review
Marianthi Papagianni et al.
DIABETES THERAPY (2018)
Antidiabetic Activity of Afobazole in Wistar Rats
R. U. Ostrovskaya et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2018)
Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality
Lynnm. Frydrych et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Liraglutide modulates gut microbiota and reduces NAFLD in obese mice
G. V. Moreira et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2018)
Effects of active and latent H-pylori infection coupled with chronic alcohol ingestion on cytokine profiles and markers of oxidative balance in men seropositive for H-pylori CagA Ab An observational study
Yiguo Jia et al.
MEDICINE (2018)
Helicobacter pylori and extragastric diseases: A review
Antonietta Gerarda Gravina et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Effects of Psychological, Environmental and Physical Stressors on the Gut Microbiota
J. Philip Karl et al.
FRONTIERS IN MICROBIOLOGY (2018)
The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
Tao Zuo et al.
FRONTIERS IN MICROBIOLOGY (2018)
The Correlation Between Circulating Ghrelin and Insulin Resistance in Obesity: A Meta-Analysis
Cai-Shun Zhang et al.
FRONTIERS IN PHYSIOLOGY (2018)
Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes
Kumar Ganesan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Linkage of Infection to Adverse Systemic Complications: Periodontal Disease, Toll-Like Receptors, and Other Pattern Recognition Systems
Shannon M. Wallet et al.
VACCINES (2018)
Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes
Haijun Liu et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis
Meng-Rui Lee et al.
CLINICAL INFECTIOUS DISEASES (2017)
α -Glucosidase and α-amylase inhibitors from seed oil: A review of liposoluble substance to treat diabetes
Hui Teng et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2017)
Influence of diabetes mellitus on immunity to human tuberculosis
Pavan Kumar Nathella et al.
IMMUNOLOGY (2017)
Improvement of glycemic state among responders to Sofosbuvir-based treatment regimens: Single center experience
Shereen Abdel Alem et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
Risk Factors for Herpes Zoster: A Systematic Review and Meta-analysis
Kosuke Kawai et al.
MAYO CLINIC PROCEEDINGS (2017)
A Protective Role of Glibenclamide in Inflammation-Associated Injury
Gensheng Zhang et al.
MEDIATORS OF INFLAMMATION (2017)
Macrophage functions in lean and obese adipose tissue
Dylan Thomas et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
Christian Milani et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2017)
Special Issue: Sulfonamides
Claudiu T. Supuran
MOLECULES (2017)
Diabetes Mellitus and Sepsis: A Challenging Association
Silvia C. Trevelin et al.
SHOCK (2017)
Molecular mimicry in Helicobacter pylori infections
Magdalena Chmiela et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review
Anne-Claire Desbois et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Diet and microbiota in inflammatory bowel disease: The gut in disharmony
Davy C. M. Rapozo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Helicobacter pylori Infection Is Associated with Type 2 Diabetes, Not Type 1 Diabetes: An Updated Meta-Analysis
Jun-Zhen Li et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2017)
Incidence and prevalence of type 2 diabetes mellitus with HIV infection in Africa: a systematic review and meta-analysis
A. Prioreschi et al.
BMJ OPEN (2017)
Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009-2014
Cintia Munoz-Quiles et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Gut Microbiota Modulation and Its Relationship with Obesity Using Prebiotic Fibers and Probiotics: A Review
Dinesh K. Dahiya et al.
FRONTIERS IN MICROBIOLOGY (2017)
Effects of Antidiabetic Drugs on Gut Microbiota Composition
Sophie A. Montandon et al.
GENES (2017)
The global diabetes epidemic: what does it mean for infectious diseases in tropical countries?
Reinout van Crevel et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
The human microbiome: an emerging tool in forensics
Jarrad T. Hampton-Marcell et al.
MICROBIAL BIOTECHNOLOGY (2017)
Biological potential of thiazolidinedione derivatives of synthetic origin
Sucheta et al.
CHEMISTRY CENTRAL JOURNAL (2017)
Repurposing metformin as a quorum sensing inhibitor in Pseudomonas aeruginosa
Hisham A. Abbas et al.
AFRICAN HEALTH SCIENCES (2017)
Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes
Hubert Kolb et al.
BMC MEDICINE (2017)
Diabetes Enhances IL-17 Expression and Alters the Oral Microbiome to Increase Its Pathogenicity
E. Xiao et al.
CELL HOST & MICROBE (2017)
Introduction to the human gut microbiota
Elizabeth Thursby et al.
BIOCHEMICAL JOURNAL (2017)
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
K. Ogurtsova et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Formulation, physicochemical characterization and in-vivo evaluation of ion-sensitive metformin loaded-biopolymeric beads
Ahmed N. Allam et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2016)
Diclofenac inhibits virulence of Proteus mirabilis isolated from diabetic foot ulcer
Abdel Halim Hegazy Wael
African Journal of Microbiology Research (2016)
Trimeric PEG-Conjugated Exendin-4 for the Treatment of Sepsis
Wonhwa Lee et al.
BIOMACROMOLECULES (2016)
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications
Hiddo J. L. Heerspink et al.
CIRCULATION (2016)
Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications
Rena M. Pollack et al.
DIABETES CARE (2016)
Antibiotic effects on gut microbiota and metabolism are host dependent
Shiho Fujisaka et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Effect of Helicobacter pylori eradication on insulin resistance among prediabetic patients: A pilot study and single-blind randomized controlled clinical trial
Ali Kachuei et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2016)
Environmental risk factors for type 1 diabetes
Marian Rewers et al.
LANCET (2016)
Glucagon like peptide-1 receptor agonists may ameliorate the metabolic adverse effect associated with antiretroviral therapy
Mehmet Gokhan Culha et al.
MEDICAL HYPOTHESES (2016)
Local Immune Response in Helicobacter pylori Infection
Derya Kivrak Salim et al.
MEDICINE (2016)
Viral infections in type 1 diabetes mellitus - why the β cells?
Anne Op de Beeck et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Association of Herpes Zoster and Type 1 Diabetes Mellitus
Hsin-Hung Chen et al.
PLOS ONE (2016)
Progressing From Metformin to Sulfonylureas or Meglitinides
Joan S. Grant et al.
WORKPLACE HEALTH & SAFETY (2016)
Helicobacter pylori and cardiovascular complications: a mechanism based review on role of Helicobacter pylori in cardiovascular diseases
Prasad G. Jamkhande et al.
INTEGRATIVE MEDICINE RESEARCH (2016)
Hepatitis C virus pathogenesis: Serum IL-33 level indicates liver damage
Abdel Halim Hegazy Wael et al.
African Journal of Microbiology Research (2015)
Sulfonylureas and their use in clinical practice
Daniele Sola et al.
ARCHIVES OF MEDICAL SCIENCE (2015)
Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections
M. Dryden et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Mechanisms of Beta Cell Dysfunction Associated With Viral Infection
Antje Petzold et al.
CURRENT DIABETES REPORTS (2015)
Effects of rifam pin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants
Damayanthi Devineni et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis
Rohit Vashisht et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity
Ningwen Tai et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2015)
Helicobacter pylori Infection Increases Insulin Resistance and Metabolic Syndrome in Residents Younger than 50 Years Old: A Community-Based Study
Li-Wei Chen et al.
PLOS ONE (2015)
Type 1 diabetes: A predictable disease
Kimber M. Simmons et al.
WORLD JOURNAL OF DIABETES (2015)
Enterovirus and type 1 diabetes: What is the matter?
Carla Sanchez Bergamin et al.
WORLD JOURNAL OF DIABETES (2015)
Association of gene variants with susceptibility to type 2 diabetes among Omanis
Sawsan Al-Sinani et al.
WORLD JOURNAL OF DIABETES (2015)
Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies
Paul Nyirjesy et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
High risk of failing eradication of Helicobacter pylori in patients with diabetes: A meta-analysis
Chika Horikawa et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Diabetes and immunity to tuberculosis
Nuria Martinez et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Diabetes mellitus and community-acquired bloodstream infections in the critically ill
Caitlin K. McKane et al.
JOURNAL OF CRITICAL CARE (2014)
Does telaprevir possess a direct antidiabetic effect?
Paulino Tallon de Lara et al.
LIVER INTERNATIONAL (2014)
Helicobacter pylori infection and diabetes: Is it a myth or fact?
Cong He et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Gut microbiota and metabolic syndrome
Davide Festi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Hypoglycemia After Antimicrobial Drug Prescription for Older Patients Using Sulfonylureas
Trisha M. Parekh et al.
JAMA INTERNAL MEDICINE (2014)
A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role
Mirella P. Hage et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2014)
Low-Grade Inflammation, Obesity, and Diabetes
Solange S. Pereira et al.
CURRENT OBESITY REPORTS (2014)
interrelationships between ghrelin, insulin and glucose homeostasis: physiological relevance
Francois Chabot et al.
WORLD JOURNAL OF DIABETES (2014)
Hepatitis C virus infection and insulin resistance
Sandip K. Bose et al.
WORLD JOURNAL OF DIABETES (2014)
Growth Inhibition of Pathogenic Bacteria by Sulfonylurea Herbicides
Jason F. Kreisberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study
Mora Murri et al.
BMC MEDICINE (2013)
Mechanisms of Glucose Lowering of Dipeptidyl Peptidase-4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes: A double-tracer study
Carolina Solis-Herrera et al.
DIABETES CARE (2013)
Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1
S. J. Richardson et al.
DIABETOLOGIA (2013)
Helicobacter pylori infection associated with high HbA1c and type 2 diabetes
Ming-Chia Hsieh et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Sulfonylureas Have Antifungal Activity and Are Potent Inhibitors of Candida albicans Acetohydroxyacid Synthase
Yu-Ting Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
James P. Garnett et al.
THORAX (2013)
Hepatitis C Virus-Induced Mitochondrial Dysfunctions
Charlene Brault et al.
VIRUSES-BASEL (2013)
Glyburide Reduces Bacterial Dissemination in a Mouse Model of Melioidosis
Gavin C. K. W. Koh et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Host Susceptibility Factors to Bacterial Infections in Type 2 Diabetes
Yunn-Hwen Gan
PLOS PATHOGENS (2013)
Host Defenses Against Zygomycetes
Emmanuel Roilides et al.
CLINICAL INFECTIOUS DISEASES (2012)
Role of helicobacter pylori infection in autoimmune diseases
Sarfaraz Ahmed Hasni
CURRENT OPINION IN RHEUMATOLOGY (2012)
Insulin Treatment Directly Restores Neutrophil Phagocytosis and Bactericidal Activity in Diabetic Mice and Thereby Improves Surgical Site Staphylococcus aureus Infection
Hidekazu Yano et al.
INFECTION AND IMMUNITY (2012)
Incidence of genital infection among patients with type 2 diabetes in the UK General Practice Research Database
Ishan Hirji et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2012)
Virus Infections in Type 1 Diabetes
Ken T. Coppieters et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Antigen Targets of Type 1 Diabetes Autoimmunity
Bart O. Roep et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity
Patrice D. Cani et al.
GUT MICROBES (2012)
Glycosylation changes as important factors for the susceptibility to urinary tract infection
Joemar Taganna et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
Considerations when prescribing trimethoprim-sulfamethoxazole
Joanne M. -W. Ho et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)
The Association Between Helicobacter pylori Infection and Insulin Resistance: A Systematic Review
Stergios A. Polyzos et al.
HELICOBACTER (2011)
Influence of esomeprazole on hypoglycemic activity of oral antidiabetic agents in rats and rabbits
Prashant D. Phadatare et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Tom L. Van Belle et al.
PHYSIOLOGICAL REVIEWS (2011)
Endocrine impact of Helicobacter pylori: Focus on ghrelin and ghrelin o-acyltransferase
Penny L. Jeffery et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Investigation of the antibacterial activity of pioglitazone
Majed M. Masadeh et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2011)
Inflammatory Concepts of Obesity
Viviane Zorzanelli Rocha et al.
INTERNATIONAL JOURNAL OF INFLAMMATION (2011)
Symptomatic Hypoglycemia Associated with Trimethoprim/Sulfamethoxazole and Repaglinide in a Diabetic Patient
Matthieu Roustit et al.
ANNALS OF PHARMACOTHERAPY (2010)
Immune cell crosstalk in type 1 diabetes
Agnes Lehuen et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Severe Dysglycemia with the Fluoroquinolones: A Class Effect?
Sherrie L. Aspinall et al.
CLINICAL INFECTIOUS DISEASES (2009)
Unusual multifocal cutaneous leishmaniasis in a diabetic patient
Ali Murat Ceyhan et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2009)
Viral Trigger for Type 1 Diabetes Pros and Cons
Christophe M. Filippi et al.
DIABETES (2008)
Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials
Konstantinos Z. Vardakas et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Global burden of obesity in 2005 and projections to 2030
T. Kelly et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Epidemiology of Diabetes and Diabetes-Related Complications
Anjali D. Deshpande et al.
PHYSICAL THERAPY (2008)
Severe hypoglycemia from clarithromycin-repaglinide drug interaction
Mogher Khamaisi et al.
PHARMACOTHERAPY (2008)
The effect of Helicobacter pylori on insulin resistance
S Aydemir et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Synthesis, characterization and in vitro antimicrobial activity of novel sulfonylureas of 15-membered azalides
MB Krajacic et al.
JOURNAL OF ANTIBIOTICS (2005)
Effects of fluoroquinolones on insulin secretion and β-cell ATP-sensitive K+ channels
A Saraya et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Pharmacokinetic interactions with rifampicin - Clinical relevance
M Niemi et al.
CLINICAL PHARMACOKINETICS (2003)
The cytochrome P4503A4 inhibitor clarithromycin increases the plasma concentrations and effects of repaglinide
M Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
